PRINCETON, N.J.--(BUSINESS WIRE)--Certara ® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that its Simcyp ® ...

Princeton-based Certara, a model-informed drug development and decision support company, announced Wednesday it is celebrating the 20th anniversary of its Simcyp Consortium. According to Certara, the ...

RADNOR, Pa., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announces the celebration of the 25 th anniversary of the ...

Simcyp will operate as a business unit within Certara maintaining its Consortium business model and its focus on population-based PBPK/PD modelling and simulation services and software which it ...

Certara, Inc., the global leader in biosimulation, today announced the release of version 20 of its Simcyp™ Physiologically-based Pharmacokinetic (PBPK) Simulator platform. Simcyp PBPK Simulator ...

PRINCETON, N.J., June 28, 2022 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Discovery Simulator, a new software designed for ...

RADNOR, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (CERT), a global leader in model-informed drug development, has released a new version of the Simcyp™ Simulator for physiologically-based ...

PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is designed ...

Simcyp, a spin-off from the UK’s University of Sheffield that specialises in virtual population-based pharmacokinetic modelling and simulation, is being acquired by translational life sciences company ...

In-silico bioequivalence approach using Simcyp’s Multi-Phase Multi-Layer Mechanistic Dermal Absorption model successfully replaced in-vivo, clinical studies in FDA ANDA approval PRINCETON, NJ – June ...

Unique capabilities expand the types of drugs, modalities, populations, and development questions modeled using the Simcyp PBPK Simulator Certara’s industry-leading Simcyp PBPK Simulator improves ...

SHEFFIELD, England--(BUSINESS WIRE)--Simcyp Limited announces its acquisition (subject to certain closing conditions) by Certara, a leading provider of drug discovery and development software and ...